MedPath

Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain
Associated Therapies
-

Pain Multidisciplinar Intervention in Major Trauma Patients

Recruiting
Conditions
Trauma
Chronic Pain
Psychological Trauma
Interventions
First Posted Date
2022-05-02
Last Posted Date
2024-08-20
Lead Sponsor
Nuria Llorach-Perucho
Target Recruit Count
80
Registration Number
NCT05355441
Locations
🇪🇸

Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain

Not Applicable
Recruiting
Conditions
Cancer Pain
Interventions
First Posted Date
2022-04-05
Last Posted Date
2024-10-16
Lead Sponsor
Assiut University
Target Recruit Count
400
Registration Number
NCT05311774
Locations
🇪🇬

Assiut University, Assiut, Egypt

Comparsion of IV Dexmedetomidine, Tramdol and Ketamine for Post Spinal Anesthesia Shivering.

Phase 3
Conditions
Post-Surgical Complication
Interventions
First Posted Date
2022-04-05
Last Posted Date
2022-04-05
Lead Sponsor
Sheikh Zayed Medical College
Target Recruit Count
71
Registration Number
NCT05311722

The Influence of Tramadol on Platelet Function

Phase 4
Completed
Conditions
Drug Toxicity
Clotting Disorder
Platelet Dysfunction
Interventions
First Posted Date
2022-02-14
Last Posted Date
2024-01-18
Lead Sponsor
Medical University of Graz
Target Recruit Count
33
Registration Number
NCT05237492
Locations
🇦🇹

Dept. of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria

Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain

First Posted Date
2021-12-28
Last Posted Date
2025-01-09
Lead Sponsor
Menarini International Operations Luxembourg SA
Target Recruit Count
538
Registration Number
NCT05170841
Locations
🇮🇹

University of L'Aquila, L'Aquila, Italy

Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

Phase 2
Withdrawn
Conditions
Pain, Chronic
Interventions
Other: Canadá placebo
Drug: Canadá
Other: Dipyrone placebo
Drug: Dipyrone
Other: Tramadol hydrochloride placebo
Drug: Tramadol hydrochloride
First Posted Date
2021-11-18
Last Posted Date
2023-09-08
Lead Sponsor
EMS
Registration Number
NCT05125978

Effect of Tramadol on Postoperative Sore Throat After General Anesthesia

Phase 4
Recruiting
Conditions
Thyroid Surgery
Post-operative Sore Throat
Intubation Intratracheal
Interventions
Other: Normal Saline
Drug: Tramadol hydrochloride
First Posted Date
2021-08-05
Last Posted Date
2024-05-13
Lead Sponsor
Affiliated Cancer Hospital of Shantou University Medical College
Target Recruit Count
168
Registration Number
NCT04991493
Locations
🇨🇳

Affiliated Cancer Hospital of Shantou University Medical College Medical, Shantou, Guangdong, China

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Phase 2
Withdrawn
Conditions
Radical Prostatectomies
Interventions
First Posted Date
2021-06-25
Last Posted Date
2022-09-06
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT04939987
Locations
🇺🇸

Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Trans Abdominis Plane (TAP) Block in Patients With Cesarean Section

Not Applicable
Conditions
Analgesia
Cesarean Section Complications
Interventions
Procedure: Transverse abdominis plane (TAP) block
Drug: Bupivacain
Drug: Tramadol
First Posted Date
2021-03-22
Last Posted Date
2021-03-22
Lead Sponsor
Armed Forces Hospital, Pakistan
Target Recruit Count
60
Registration Number
NCT04809532
Locations
🇵🇰

Madiha Ahmed, Islamabad, Pakistan

🇵🇰

Department of Pediatrics, Rawalpindi, Punjab, Pakistan

PROUD Study - Preventing Opioid Use Disorders

Phase 4
Terminated
Conditions
Opioid Use
Anesthesia
Interventions
Behavioral: Guided mindfulness exercises
Other: Self-administered aromatherapy
Drug: Baby aspirin
Drug: Tylenol/Acetaminophen
Drug: Pregabalin
Drug: Prednisone
Drug: Meloxicam
Drug: Prilosec
Drug: Tramadol
Drug: Voltaren
Drug: Zofran
Drug: Pepcid
Drug: Reglan
Drug: Versed
Drug: Lidocaine
Drug: Propofol
Drug: Ancef
Drug: Tranexamic Acid (TXA)
Drug: Decadron
Drug: Bupivacaine hydrochloride
Drug: Toradol
First Posted Date
2021-02-23
Last Posted Date
2023-06-22
Lead Sponsor
Emory University
Target Recruit Count
57
Registration Number
NCT04766996
Locations
🇺🇸

Emory University Orthopaedic and Spine Hospital, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath